Endobetix's Other Investors

Endobetix raised a round of funding on , . Investors include The Trendlines Group.

Endobetix is developing a minimally invasive, nonsurgical implant to treat T2D and obesity that mimics the hormonal benefits offered by bariatric surgery.…

Articles about Endobetix's Other Investors: